Dr. Carolin Melati Daamen

• Spearheaded global Integrated Evidence Generation Plan, bridging critical data gaps through insights from Thought Leaders and key markets. • Directed scientific communications including over 20 publications and congress presentations, enhancing the visibility of Deucravacitinib's clinical value. • Provided strategic input on phase III and post-marketing study protocols, supporting global clinical development alignment.

• Owned global medical strategy and launch execution for Deucravacitinib in psoriasis across 25+ countries, driving affiliate readiness and scientific engagement. • Cultivated critical relationships with global Thought Leaders, academic institutions, professional societies and organized advisory boards, directly shaping global strategy and messaging. • Drove international medical education strategy and publication plans, increasing HCP awareness and brand visibility across key therapeutic congresses.

• Managed 2 direct and 8 functional reports to deliver high-impact German medical plans across Dermatology and Rheumatology. • Developed pre-launch strategy for Deucravacitinib in Germany and established BMS’s dermatology presence nationally, facilitating rapid post-launch uptake. • Oversaw pipeline assets in Rheumatoid Arthritis, Psoriatic Arthritis, Lupus, Myositis, and Sjogren’s, resulting in comprehensive pipeline readiness and medical positioning.

Launching new indications and launch preparation - Conceptual design, set-up, supervision of Investigator Sponsored Trials and Non-Interventional Studies - KOL liaison and medical support of clinical phase II/III trials - KOL-Management - Collaborative work/running strategic projects with Global, World Wide Team and US Team - Cross-functional work with Field Medical Team, Marketing, Market Access, Regulatory, Legal,.. - Strategic Medical Planning - Design, planning, coordination and execution of Symposia

Brand Management Immunologie, Sarilumab/Kevzara, Dupilumab, pre-launch Marketing, Disease Awareness Campaign, Multichannel Marketing, Conceptual Design of Congress Booth.

Lipids Cardiovascular – Medical Management Clexane® + Synvisc® - Betreuung Meinungsbildner – Koordination medizinisch-wissenschaftlicher Aktivitäten – Global Brand Team – Cross-funktionale Zusammenarbeit – Zusammenarbeit mit Kardiologen und Orthopäden – Produktkampagnen – Disease Awareness – Advisory Board – Interaktion mit Regulatory – Koordination medizinischer Publikationsaktivitäten, national und international – Konzeption und Durchführung medizin. Schulungen - Biosurgery Market Access Leadership Team.

Achieved a first-author publication (PMID: 22502800). Established an ovalbumin-dependent mouse model of allergic airway inflammation.

Immunology

Immunologie